| NCT06940739 | A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel | RECRUITING | PHASE1, PHASE2 | 2025-03-11 | 2032-07 | 2032-06 |
| NCT06481592 | A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. | RECRUITING | PHASE2 | 2024-10-29 | 2029-11 | 2028-05 |
| NCT06566092 | Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants | RECRUITING | PHASE1 | 2024-03-28 | 2028-07 | 2026-07 |
| NCT05727904 | Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. | RECRUITING | PHASE3 | 2023-03-30 | 2030-03-01 | 2028-03-01 |
| NCT05361174 | A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer | RECRUITING | PHASE1, PHASE2 | 2022-07-20 | 2027-06 | 2025-06 |
| NCT04614103 | Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer | RECRUITING | PHASE2 | 2021-05-07 | 2031-12 | 2030-12 |
| NCT04155710 | Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL | COMPLETED | PHASE1, PHASE2 | 2020-02-19 | 2024-12-02 | 2024-11-11 |
| NCT03645928 | Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors | RECRUITING | PHASE2 | 2019-05-07 | 2029-08-09 | 2029-08-09 |
| NCT03419559 | Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer | WITHDRAWN | PHASE2 | 2018-02-28 | 2024-12 | 2021-12 |
| NCT03108495 | Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma | TERMINATED | PHASE2 | 2017-06-22 | 2025-08-22 | 2025-08-22 |
| NCT03083873 | Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck | COMPLETED | PHASE2 | 2017-01-09 | 2022-08-08 | 2022-08-08 |
| NCT02360579 | Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma | COMPLETED | PHASE2 | 2015-09-24 | 2024-10-24 | 2024-10-24 |